Rewalk Robotics (RWLK) Sets New 12-Month Low at $0.21

Rewalk Robotics Ltd (NASDAQ:RWLK)’s share price reached a new 52-week low during trading on Friday . The company traded as low as $0.21 and last traded at $0.22, with a volume of 864909 shares trading hands. The stock had previously closed at $0.23.

A number of equities analysts have recently commented on the stock. Zacks Investment Research upgraded shares of Rewalk Robotics from a “hold” rating to a “buy” rating and set a $1.25 price objective for the company in a research report on Thursday, August 30th. Oppenheimer set a $2.00 price objective on shares of Rewalk Robotics and gave the company a “buy” rating in a research report on Friday, August 24th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $1.85.

The company has a market cap of $8.23 million, a price-to-earnings ratio of -0.23 and a beta of 0.77.

Rewalk Robotics (NASDAQ:RWLK) last announced its earnings results on Thursday, November 8th. The medical device company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.01. The business had revenue of $1.62 million for the quarter, compared to the consensus estimate of $2.12 million. Rewalk Robotics had a negative net margin of 352.11% and a negative return on equity of 3,654.32%. On average, sell-side analysts expect that Rewalk Robotics Ltd will post -0.67 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was first published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at

About Rewalk Robotics (NASDAQ:RWLK)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

Recommended Story: What is the NASDAQ Stock Market?

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit